FREE Case Review (866) 588-0600

Levaquin Nerve Damage Lawsuits Filed in New Jersey

Johnson & Johnson has been hit with a new round of lawsuits filed in federal court in New Jersey, alleging that Levaquin caused users to develop severe nerve damage.

Johnson & Johnson has been hit with a new round of lawsuits filed in federal court in Newark, New Jersey, alleging that its antibiotic drug Levaquin (generic: levofloxacin) caused users to develop severe nerve damage.

Free Confidential Lawsuit Evaluation: If you or a loved one was injured by Levaquin side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

What’s the Problem?

August 15, 2016 – At least 13 Levaquin lawsuits involving 18 plaintiffs have been filed against J&J and its Janssen subsidiary in the District of New Jersey this month alone.

The cases may ultimately be consolidated into the multidistrict litigation (MDL) in the District of Minnesota for complaints alleging peripheral neuropathy from Levaquin and 2 other similar antibiotics, Avelox (moxifloxacin) and Cipro (ciprofloxacin).

The lawsuits alleging neuropathy from Levaquin represent the second wave of litigation over the antibiotic, following hundreds of complaints linking it to tendonitis and other tendon injuries. An MDL for that group of suits was formed in Minnesota in 2008, and the litigation is still ongoing.

The neuropathy suits follow a May 12 warning by the U.S. Food and Drug Administration (FDA) stating that “disabling” side effects of Levaquin and other similar fluoroquinolone antibiotics “generally outweigh the benefits” for patients with sinusitis, bronchitis and urinary tract infections (UTIs) who have other treatment options.

Levaquin is currently the most-prescribed antibiotic medication in the world, generating $1.6 billion in revenue (6.5% of J&J’s total revenue) in 2007 alone. The complaints allege the company failed to adequately warn the public and medical communities about the risks of neuropathy associated with the drug. From 2004 to 2013, Levaquin’s label carried a warning indicating that neuropathy was “rare” among users, and could be avoided by quitting the drug upon appearance of certain symptoms. However, neuropathy often appears rapid and discontinuing use will not ensure it can be reversed, according to the lawsuits.

Do I Have a Levaquin Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in levaquin lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.

Free Confidential Case Evaluation: Again, if you were injured by Levaquin, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
Awards & recognition